Relations of Visceral and Abdominal Subcutaneous Adipose Tissue, Body Mass Index, and Waist Circumference to Serum Concentrations of Parameters of Chronic Inflammation

Obesity Facts - Tập 9 Số 3 - Trang 144-157 - 2016
Inga Schlecht1, Beate Fischer1, Gundula Behrens1, Michael F. Leitzmann1
1Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany

Tóm tắt

<b><i>Background: </i></b>Different measures of body fat composition may vary in their relations to parameters of chronic inflammation. <b><i>Methods: </i></b>We assessed the relations of visceral (VAT) and subcutaneous adipose tissue (SAT), BMI, and waist circumference (WC) to serum concentrations of high-sensitive C-reactive protein (hs-CRP), tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), resistin, and adiponectin in 97 healthy adults using multivariate linear regression models, adjusted for age, sex, smoking, physical activity, menopausal status, and use of aspirin or non-steroidal anti-inflammatory drugs (NSAIDs). Parameters of chronic inflammation were mutually adjusted. <b><i>Results: </i></b>VAT (β = 0.34), SAT (β = 0.43), BMI (β = 0.40), and WC (β = 0.47) were all significantly associated with hs-CRP. BMI was additionally inversely related to adiponectin (β = -0.29). In exploratory subgroup analyses defined by gender, BMI, smoking, and use of aspirin or NSAIDs, VAT was the strongest indicator for increased levels of IL-6, SAT was the most consistent indicator for increased levels of hs-CRP, and BMI was the most consistent indicator for decreased levels of adiponectin. WC showed to be a weak indicator for increased levels of hs-CRP and decreased levels of adiponectin. <b><i>Conclusion: </i></b>VAT, SAT, BMI, and WC show distinct associations with parameters of chronic inflammation. Whether these differences reflect differential metabolic risks requires clarification by longitudinal studies.

Từ khóa


Tài liệu tham khảo

10.1016/S0140-6736(10)62037-5

10.1038/nrendo.2009.78

10.1016/S0140-6736(08)60269-X

10.1161/CIRCULATIONAHA.106.675355

10.1038/sj.ijo.0803144

10.1002/oby.20135

10.1515/hmbci-2014-0009

10.1089/met.2009.0089

10.1074/jbc.M103241200

10.1586/14779072.6.3.343

10.2337/diabetes.50.10.2199

10.1016/S0140-6736(02)07281-1

10.1210/jc.87.5.2407

10.1210/jc.2003-030519

10.1210/jc.2003-031410

10.1161/01.CIR.0000131514.71167.2e

10.1016/j.amjcard.2006.01.045

10.1016/j.atherosclerosis.2010.10.017

10.1016/j.atherosclerosis.2005.03.010

10.1016/j.atherosclerosis.2005.04.011

10.1161/01.ATV.19.4.972

10.1038/sj.ijo.0801723

10.1038/sj.ijo.0801792

10.1161/01.ATV.21.6.961

10.1161/01.ATV.0000029781.31325.66

10.1159/000345045

10.1530/eje.0.1490331

10.1152/japplphysiol.01046.2012

10.1016/j.metabol.2007.06.014

10.1111/j.1462-8902.2003.0342.x

10.1161/CIRCULATIONAHA.107.710509

10.1016/j.amjcard.2005.02.051

10.1507/endocrj.EJ11-0132

10.2337/db07-0932

10.1016/j.diabres.2004.11.007

10.1038/oby.2008.627

10.1016/j.metabol.2010.02.017

10.1038/oby.2003.137

10.2337/dc08-1733

10.1007/s00125-003-1074-z

10.1016/j.trsl.2014.04.008

10.1016/j.metabol.2014.07.012

10.1161/01.ATV.21.6.961

10.1016/j.numecd.2014.04.017

10.1016/j.yhbeh.2014.02.007

10.1016/j.yhbeh.2012.04.011

10.2337/diabetes.52.12.2882

10.1093/jnci/dju294

10.1016/j.jaut.2009.12.003

10.1136/bmj.f3195

10.1007/s10549-014-3030-7

10.1093/oxfordjournals.aje.a008934

10.1210/jc.2004-0395

10.1016/j.metabol.2004.10.015

10.1093/humrep/deh010

10.1210/jc.2003-030898

10.1055/s-2002-38241

10.1210/jc.2002-021808

10.1016/j.cccn.2003.09.009

10.1016/S0006-291X(02)02841-3

Thông tin
Thông tin xuất bản

Obesity Facts

Tập 9 Số 3

144-157

Thông tin tác giả